A CITF-funded study, published in Transplant Cell Therapy, from Dr. Deepali Kumar’s team (University of Toronto) shows that a third dose of COVID-19 vaccine resulted in stronger humoral and cell-mediated immunity in allogeneic stem cell transplant (Allo-SCT) recipients, when compared to the initial two-dose vaccine regimen.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed